== Side effects ==

 
Side effects such as unconsciousness or coma, hyperemesis, nausea, seizures, convulsions, tachycardia, bradycardia, mydriasis, syncope, spontaneous urinating and defecating, shortness of breath, somnolence, respiratory acidosis, metabolic acidosis, collapse, lower limbs paralysis, chest pain, aggression and severe disturbance of behaviour were reported.<ref name="EMCDDA"/><ref>{{cite journal|first1=Alice|last1=Seywright|first2=Hazel J.|last2=Torrance|first3=Fiona M.|last3=Wylie|first4=Denise A.|last4=McKeown|title=Analysis and clinical findings of cases positive for the novel synthetic cannabinoid receptor agonist MDMB-CHMICA|url=http://www.tandfonline.com/doi/abs/10.1080/15563650.2016.1186805|journal=Clinical Toxicology|date=13 September 2016|issn=1556-3650|pages=632–637|volume=54|issue=8|doi=10.1080/15563650.2016.1186805|first5=David J.|last5=Lowe|first6=Richard|last6=Stevenson|pmid=27213960}}</ref><ref>{{cite journal|first1=Simon L.|last1=Hill|first2=Javad|last2=Najafi|first3=Michael|last3=Dunn|first4=Paul|last4=Acheampong|title=Clinical toxicity following analytically confirmed use of the synthetic cannabinoid receptor agonist MDMB-CHMICA. A report from the Identification Of Novel psychoActive substances (IONA) study|url=http://www.tandfonline.com/doi/full/10.1080/15563650.2016.1190980|journal=Clinical Toxicology|date=13 September 2016|issn=1556-3650|pages=638–643|volume=54|issue=8|doi=10.1080/15563650.2016.1190980|pmid=27251903|first5=Ashraf|last5=Kamour|first6=Johann|last6=Grundlingh|first7=Peter G.|last7=Blain|first8=Simon H. L.|last8=Thomas}}</ref><ref>{{cite journal|first1=Robert J.|last1=Tait|first2=David|last2=Caldicott|first3=David|last3=Mountain|first4=Simon L.|last4=Hill|title=A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment|url=http://www.tandfonline.com/doi/abs/10.3109/15563650.2015.1110590|journal=Clinical Toxicology|date=2 January 2016|pages=1–13|volume=54|issue=1|doi=10.3109/15563650.2015.1110590|pmid=26567470|first5=Simon|last5=Lenton}}</ref><ref>{{cite journal|first1=Chitra|last1=Meyyappan|first2=Loretta|last2=Ford|first3=Allister|last3=Vale|title=Poisoning due to MDMB-CHMICA, a synthetic cannabinoid receptor agonist|url=http://www.tandfonline.com/doi/full/10.1080/15563650.2016.1227832|journal=Clinical Toxicology|date=2016|issn=1556-3650|pages=1–2|pmid=27635694|doi=10.1080/15563650.2016.1227832}}</ref><ref>{{cite journal|first1=Matilda|last1=Bäckberg|first2=Luiza|last2=Tworek|first3=Olof|last3=Beck|first4=Anders|last4=Helander|title=Analytically Confirmed Intoxications Involving MDMB-CHMICA from the STRIDA Project|url=https://link.springer.com/article/10.1007/s13181-016-0584-2|journal=Journal of Medical Toxicology|date=2016|issn=1937-6995|doi=10.1007/s13181-016-0584-2|pmid=27638057}}</ref>
